Gynecologic oncology has seen a tremendous growth as a surgical specialty over the past four decades. However, many regions of the world still lack structured training programs in this discipline. The aim of this article is to identify the essential skills for a gynecologic oncologist to be able to provide optimal care to women diagnosed with gynecologic cancer. Where the evidence exists in the literature we identify the learning curve necessary. Identifying essential skills required for the practice of gynecologic oncology should assist in standardizing care provision globally, and could be a starting point for health systems beginning structured training programs. Development of surgical skills requires adequate training, mentorship, and self-evaluation as an ongoing process beyond the years spent in training programs.
| INTRODUCTION
Gynecologic oncology, introduced as a subspecialty of obstetrics and gynecology over four decades ago, has evolved considerably in recent years. The first step in diagnosis, staging, and treatment of gynecologic cancer is surgical intervention in almost all cases. The types of gynecologic cancers where surgical intervention may be needed are cervical, uterine or endometrial, ovarian, vulvar, and vaginal cancers; for these, the procedures may range from staging, debulking, total/ radical hysterectomy, unilateral/bilateral salpingo-oophorectomy, omentectomy, and lymph node removal, among others. Ovarian cancer is a unique disease where two-thirds of cases are advanced at presentation, with peritoneal carcinomatosis, rectosigmoid involvement, splenic hilum disease, diffuse miliary nodules on mesentery/ bowel, para-aortic nodal disease, and diaphragm disease. Surgical cytoreduction is an essential part of treatment for ovarian cancers.
Heterogeneity exits across various health systems globally regarding the level of surgical skill and team responsible for providing primary surgical care. Few regions of the world have structured training programs in gynecologic oncology, with an increasing number of countries/regions recognizing the need for structured training. In some countries, surgical management of gynecologic cancer is part of the wider specialty of surgical oncology. However, in the vast majority of health systems, gynecologists-with or without the help of general surgeons-undertake primary surgical management. It is important to note that owing to the varied presentation of gynecologic cancer, it is not unusual for the primary surgery to have been carried out by a general surgeon. There is increasing literature evidence that treatment outcomes, as judged by survival figures, are improved when specialists trained in gynecologic oncology undertake surgical management. 1, 2 Given the wide disparities in available resources globally, and the burden of disease in economically less privileged parts of the world, a pragmatic approach is taken in the present article. Effort has been made to distinguish between what we consider mandatory skills and desirable skills. Additionally, we have identified a set of optional skills for procedures that are currently not part of mainstream practice.
Mandatory skills are the present standard of care, and which a gynecologic oncologist should be able to perform routinely in their individual practice.
Desirable skills are those that a gynecologic oncologist should be able to perform with the help of other specialty colleagues in a lowvolume center or with or without the assistance of specialty colleagues in a high-volume center. These include procedures that involve allied surgical specialties such as urological, colorectal, plastic, and upper gastrointestinal surgery. Some of these desirable skills currently lack level 1 evidence, but will impact on patient care and quality of care in years to come. A gynecologic oncologist should learn these skills during training and may require help from specialty colleagues during the initial learning curve.
Optional skills are those that currently do not have level 1 evidence and are performed in a research context but are likely to be accepted as standard practice. Optional skills are associated primarily with new technologies that may become part of standard care in the future and are therefore not discussed in detail in this article.
Depending on the resource setting of individual centers and region of the world, some of the procedures mentioned in the "desirable" category might be routine procedures in daily practice.
In our review, we have tried to identify the learning curve for individual procedures where possible. Given that the concept of a learning curve has only been used in the context of newer technologies, beginning with laparoscopy, this information is lacking for most of the "traditional" procedures in gynecologic oncology.
| TRAINING IN GYNECOLOGIC ONCOLOGY
Most regions offering structured training programs in gynecologic oncology define the scope of surgical procedures that trainees are expected to gain experience in during fellowship training. 3 
| SURGICAL SKILLS

| Radical hysterectomy
Any discourse on surgical skills in gynecological oncology must start with radical hysterectomy for cervical cancer (Fig. 1 Table 2 .
| Nerve-sparing radical hysterectomy
Various authors have described nerve-sparing radical hysterectomy (NSRH). The essential component of the technique is to identify the inferior hypogastric nerves (in the mesoureter) that contain the autonomic nerves to the bladder, rectum, and vagina. The aim of NSRH is to prevent or contain the severity of bladder, bowel, and sexual dysfunction resulting from the damage to the autonomic nerve supply. 9 NSRH has been criticized for a lack of standardized surgical description. A recent systematic review of available evidence and meta-analysis of data from selected high-quality studies suggested that the procedure
is safe with oncologic outcomes comparable to conventional radical hysterectomy. 10 Time to micturition, as a surrogate marker of bladder function, was significantly shorter in the NSRH group. 10 The review identified significant heterogeneity in the studies included, and a significant proportion of the women in either group received adjuvant radiotherapy-an independent factor impacting on quality of life indices.
| Radical trachelectomy and fertility-sparing surgery for cervical cancer
Cervical cancer, with its bimodal peak in incidence, is often diagnosed in women of reproductive age. With increasing age of attempted child bearing, especially in high-resource countries, fertility-preserving surgery for gynecologic cancers is at the forefront of consideration, along with oncologic outcomes and quality of life issues. Dargent is credited with pioneering the concept of radical vaginal trachelectomy, followed by description of an abdominal approach by Smith et al. 11 Radical vaginal trachelectomy (RVT) had been the preferred approach for many years, especially in Europe, and the bulk of the data on safety comes from just over 1300 cases reviewed in the literature. 12 The oncologic outcomes were acceptable, with a reported recurrence rate of 4% and a 2% rate of death related to recurrent disease in women with node-negative disease. 12 Abdominal radical trachelectomy (ART) has gained popularity over the past decade owing to familiarity with the abdominal approach and its less resourceintensive nature for equipment and training. Data on oncologic safety are more heterogeneous for ART as the procedure has been attempted and results reported for tumors larger than those in VRT series. A recurrence rate of 4% has been reported from pooled data amounting to around 350 procedures.
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Either VRT or ART is acceptable for carefully selected patients who are committed to fertility preservation, and who are diagnosed with squamous cell cancers, adenocarcinoma, or adenosquamous carcinomas less than 2 cm in size. Careful patient selection will minimize the rates of failed or abandoned procedures, with the exception of 10%-12% of patients who will still require adjuvant treatment following trachelectomy. 
| Pelvic lymph node dissection for cervical and endometrial cancers
Cervical cancer staging does not take into account pelvic nodal status.
However, nodal status has a significant impact on postsurgical treatment planning and prognostication in cervical cancer.
Nodal status is an essential part of the surgicopathologic staging for endometrial cancer. The pelvic component of the nodal dissection is essentially the same for the two pathologies.
The boundaries of pelvic nodal dissection are defined as follows:
medial extent limited by the internal iliac artery and its continuation as the obliterated umbilical/hypogastric artery; lateral boundary of the genitofemoral nerve overlying the psoas muscle; distal limit defined by the circumflex iliac vein crossing the external iliac artery; deep dissection is usually limited to the obturator nerve and the proximal limit at the common iliac artery. The proximal limit has been variably described between the bifurcation of the common iliac to its origin at the bifurcation of the aorta.
| Minimally invasive surgery
Laparoscopic surgery has irreversibly shifted the paradigm of training in gynecological surgery. With the introduction of the levonorgestrel intrauterine system for the treatment of abnormal benign uterine bleeding, the incidence of hysterectomy has dropped sharply. This, coupled with a longer learning curve for laparoscopic surgery, has had an impact on the available opportunities for both learning and training in laparoscopic surgery for gynecologists and gynecologic oncolo- 
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Laparoscopic hysterectomy is resource intensive owing to the capital outlay for equipment costs and longer theatre times, but these costs are offset by a lower incidence of postoperative complications and shorter hospital stay. 
| Laparoscopic hysterectomy for endometrial cancer
Endometrial cancer is the most common gynecologic cancer in highincome countries. It is certainly the most common gynecologic malignancy in the USA, Australia, and Europe-regions where the rates of obesity are high and from where the bulk of published literature on the safety and successful introduction of laparoscopic approach has been reported. 19 Given that the oncologic outcomes and survival
compare favorably to open surgery, as evident from prospective randomized controlled trials, laparoscopic surgery for early stage endometrial cancer should be considered as the standard management. The difference in quality of life between the two groups levels off at 6 months after surgery. Surgical skills for management of endometrial cancer are shown in Table 3 .
The success of laparoscopic surgery can be limited by both patient and surgeon limitations, as highlighted by the Gynecology Oncology Group (GOG) Lap 2 study. 21 While operative difficulty due to high BMI was cited as the leading reason for conversion to laparotomy, the authors do allude to level of surgeon experience as a possible factor in the relatively higher conversion rate, compared with the LACE Trial. 17, 22 It should be noted that over 90% of patients underwent pelvic and para-aortic nodal staging in the Lap 2 study. 
| Laparoscopic radical hysterectomy for cervical cancer
There is no definitive conclusion on the role of minimally invasive surgery for surgical management of cervical cancer. While laparoscopic/ robotic surgery brings with it the advantages of minimally invasive procedures to women needing to undergo radical hysterectomy and nodal dissection, the only data in the literature are from single institution or single surgeon series. Data from retrospective and single institution series suggest that laparoscopic and robotic radical hysterectomy are probably associated with acceptable oncologic outcomes, but the data are limited and long-term follow-up information is lacking. 23 We require data from adequately designed, randomized controlled trials to categorically state that a minimally invasive approach T A B L E 3 Surgical skills for management of endometrial cancer. The data from a single institution study, where all surgeries were performed by a single surgeon, suggest that the learning curve for laparoscopic radical hysterectomy with pelvic and/or para-aortic lymph node dissection can be as high as the first 50 cases before there was a significant improvement in surgical outcomes and reduction in complication rates. 
| Laparoscopic pelvic lymph node dissection
The ability to carry out pelvic lymph node dissection laparoscopically should be an essential skill, together with laparoscopic hysterectomy,
given that a significant proportion of these patients would require comprehensive staging surgery to include pelvic with or without para-aortic lymph node assessment (Fig. 2) . This further adds to the learning curve with increased surgical risks of injury to the ureter, pelvic vessels, and nerves. Teaching advanced laparoscopic procedures for pelvic malignancies adds to the complications resulting from the procedure. 15 When compared with open surgery, minimally invasive surgery did not compromise on nodal count or detection of nodal metastatic disease, but was associated with significantly lower blood loss and hospital stay. 
| Para-aortic lymph node dissection
Lymphatic drainage of the ovaries and uterine body along the ovarian lymphatics follows their embryonic origin and blood supply from the para-aortic region. Para-aortic lymph node dissection is an essential part of staging for apparent early stage ovarian cancer and for highrisk endometrial cancer. Para-aortic lymph nodes may be microscopically involved in 18%-24% of cases of apparent Stage I and II ovarian cancer. 26, 27 Additionally, debulking of para-aortic nodal disease in a subset of advanced ovarian cancer with predominantly nodal spread, and in some cases of endometrial cancer, presents unique anatomic challenges owing to the proximity of the nodal disease to important vessels-namely the inferior mesenteric artery, renal vessels, and proximal ovarian vessels; and vital structures such as the ureters and duodenum. Debulking of para-aortic nodal disease requires dexterity and an intimate knowledge of the anatomy of the region (Figs 3a and 3b) .
F I G U R E 2 Open para-aortic node dissection and robotic pelvic node dissection.
F I G U R E 3 (A) Bulky para-aortic nodal disease; (B) Para-aortic nodal debulking.
(A) (B)
The first learning step in performing complex para-aortic nodal debulking is to learn para-aortic lymph node dissection as part of the aforementioned staging procedures with relatively normal anatomy.
Traditionally, this procedure has been performed as open surgery and most of the skillset is still limited to the open approach in the vast majority of the centers. Performing para-aortic lymph node dissection laparoscopically is an additional challenge, with yet another steep learning curve. Querleu et al. had the foresight to study the learning curve for laparoscopic para-aortic lymph node dissection in a porcine model in the initial days of laparoscopy. 28 They noted a learning curve of 14 cases to achieve adequate lymph node retrieval and the ability to complete the procedure laparoscopically without need for conversion to laparotomy for complications. 28 It is expected that the learning curve would be even longer for surgical training with patients.
The robotic-assisted minimally invasive approach has a shorter learning curve, an increased ability to perform complex procedures, such as high para-aortic lymph node dissection in women with high BMI, and low conversion rates. Single institution prospective data and multicenter retrospective data have indicated the feasibility of roboticassisted para-aortic lymph node dissection, with low conversion rates and acceptable morbidity.
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Currently there is no evidence on the clinical superiority of the robotic-assisted approach compared with traditional laparoscopic surgery in the management of endometrial cancer.
| Sentinel lymph node detection for pelvic cancers
Evidence for sentinel lymph node (SLN) detection for endometrial and cervical cancers has largely been described in the context of lap- when each hemipelvis is used as a unit rather than using bilateral detection in the same patient as the end point, which may only be in the range of 50%-60%. 
| Surgery for vulvar cancer
Vulvar cancer is a rare condition, accounting for approximately 5% of all gynecologic cancers and less than 1% of all cancers diagnosed in women. Typically, vulvar cancer has been considered a disease of old age, but is increasingly being diagnosed in younger women.
Until the pioneering work of Taussig and Way in the middle of 20th century, the outcome for women diagnosed with vulvar cancer was uniformly poor. Table 4 .
The technique for inguinofemoral lymph node dissection has also undergone a major shift, from the days when removal of skin overlying the femoral triangle and the skin bridge between the vulva and the groin was advocated, to an increasingly conservative surgical approach that can be carried out through much smaller incisions. The dissection should aim to remove all lymph nodes medial to the femoral artery, both superficial and deep to the cribriform fascia. 
| Groin sentinel lymph node detection
Detection of SNL in the groin or inguinofemoral group of lymph nodes has been around for several years. Although there are no randomized controlled trials on its efficacy and safety, data are available from two multicenter prospective observational studies on its feasibility and safety in unifocal vulvar cancers under 4 cm in maximal dimension.
Concerns related to false-negative rates persist, but the procedure is an option available to women who cannot [owing to medical issues] or would not undergo full lymph node dissection (Fig. 5) . Full lymph node dissection should still be considered as the gold standard of care in women presenting with vulvar cancer.
Long-term, disease-specific, and survival data following performance of the sentinel node procedure from the GROningen
INternational Study on Sentinel Nodes in Vulvar cancer (GROINSS-V)
I was recently published. 36 This is one of the two largest prospective observational studies on the role of sentinel nodes in vulvar cancer.
The long-term data suggest an isolated groin recurrence rate of 2.5%
for SLN-negative patients with vulvar tumors less than 4 cm who only underwent SLN detection without inguinofemoral lymph node dissection. All recurrences were diagnosed within 16 months of first surgery.
All patients diagnosed with isolated groin recurrences succumbed to the disease.
The main reason for selecting the SLN procedure over complete inguinofemoral lymph node dissection is to avoid a 50%-70% risk of lower limb lymphedema following the removal of all groin lymph nodes. 37 The risk rises to almost 100% if surgery is followed by adjuvant radiotherapy. On the other hand, groin recurrences are usually fatal, as reported in several series. The inclination to prevent lower limb lymphedema should be balanced against patient perceptions of risks of the procedure. In an Australian study, 80%
of women who had previously been treated for vulvar cancer stated that they would choose complete lymph node dissection over the SLN procedure if the quoted false-negative rate for SLN was 5%. 37 Most reliable data on the learning curve for adequate performance of the SLN procedure come from studies on breast cancer.
It was noted that a surgeon needed to perform at least 23 procedures to achieve over a 90% detection rate, with incremental gains in the success of SLN detection to 95% with over 30 procedures.
Authors of the GOG 173 study have alluded to lack of surgeon experience and low volume of cases per surgeon as factors contributing to the false-negative rate. They emphasized institutional and individual surgeon competence, as well as the ability of the institution to provide ultrastaging of the SLN to detect low-volume metastatic disease for the SLN procedure to be safe and acceptable as a surgical option. 
| Plastic surgery for vulvar cancer
Long-term data from the GROINSS-V study would suggest that 40% of women experience a recurrence of vulvar cancer over a 10-year follow-up. 36 This means that nearly one in two women would require repeat surgery for vulvar cancer. A significant proportion of women present with a large-volume primary tumor that may require plastic reconstructive procedures to close the defect with good blood supply and avoid undue tension on the wound. Re-excision for recurrent vulvar cancer after previous radiotherapy is associated with a high risk of wound complications, and plastic repair with nonirradiated musculocutaneous grafts offers the best chance to close the defect and promote healing as they bring fresh blood supply to the affected area.
Plastic surgical procedures can offer some semblance of normal appearance after a surgical procedure that may leave a patient with significant disfigurement of the vulvar region. 
| Surgery for advanced stage ovarian cancer
Ovarian cancer presents with peritoneal and/or nodal metastatic disease in 75% of women at diagnosis. Gynecologic oncology has witnessed an increasingly aggressive approach to cytoreductive surgery for ovarian cancer since the time Meigs described the benefit of reduction in tumor volume, to Griffiths' landmark paper that provided the first scientific evidence of an inverse relationship between tumor volume and patient survival. The definition of "optimal cytoreduction" has changed over the years to less than 2 cm maximal residual disease to the current definition of less than 1 cm residual disease as defined by the GOG.
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The consensus from the Gynecological Cancer InterGroup (GCIG)
Fourth Ovarian Cancer Consensus Conference in 2010 was to define "optimal debulking" as the absence of any residual disease or no gross residual disease.
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The scope of surgical resections undertaken by a gynecologic oncologist has progressively expanded to include small and large bowel resections, diaphragmatic surgery (Figs 6a and 6b) , splenectomy, distal pancreatectomy, subsegmental liver resection, and mesenteric peritoneal resection. In some regions the scope has gone even further to include partial/sleeve gastrectomy, cholecystectomy, and resection of disease from the porta hepatis. Surgical skills for management of ovarian cancer are shown in Table 5 .
The risks of complications and adverse impact on quality of life increase surgical procedures become more complex. The decision to perform additional surgical procedures should be based on presentation, performance status, impact on symptomatology, and ability to achieve no gross residual disease. In a retrospective review of 2655 women who participated in the GOG 182 study, performance of upper abdominal surgical procedures that largely included diaphragmatic surgery had an equivocal impact on progression-free survival and overall survival. 42 The positive impact of these procedures was noted as a function of the proportion of women achieving no gross residual disease (i.e. women who had no gross residual disease had a significantly superior progression-free survival and overall survival compared with those who did not achieve no gross residual disease). The impact of upper abdominal procedures on progression-free survival or overall survival was not statistically significant, leading the authors to conclude that these procedures should only be performed if no gross residual disease is achievable. 42 This is probably the most important message from the available literature on extended cytoreductive procedures either alone in combination. The complexity and extent of the procedure should be weighed against the likely morbidity, preoperative status of the patient, their wishes, and ability to achieve no gross residual disease.
The other issue that arises from the retrospective review of surgical outcomes from the GOG 182 and SCOTROC-1 trials is whether ability to achieve no gross residual disease is a function of better disease biology rather than maximal surgical effort. 43, 44 The authors argue that maximal surgical effort to include increasingly complex procedures cannot overcome aggressive disease biology.
Extended cytoreductive procedures, especially a combination of complex surgical procedures in addition to standard pelvic surgery and omentectomy, increase the risk of 30-day major morbidity as well risk of 30-day mortality. Complex surgery was an independent risk factor associated with short-term major adverse events in both univariate and multivariate analysis. These adverse events were noted in nearly one in five patients undergoing extended cytoreduction.
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A meta-analysis of treatment outcomes involving over 2000 patients revealed a survival benefit of 3 months for each 10% increase in the proportion of women who underwent complete debulking surgery for advanced ovarian cancer. 46 The data were derived from 40 cohorts of retrospective, prospective nonrandomized, retrospective case-controlled studies, and personal communications. A further meta-analysis of treatment outcomes for over 13 000 patients in the era of changing treatment paradigms showed a 2.3 month survival advantage for each 10% increase in the proportion of women undergoing complete debulking. 47 It is important to note that while this information has influenced our practice, this is post hoc analysis of data that was not originally powered or intended to answer the question of impact of surgical debulking on survival outcomes. In the absence of any relevant data from well-designed randomized controlled trials, this is the best information currently available to be able to counsel women on the benefits of extended cytoreduction for ovarian cancer.
Despite the information from these studies with a large volume of patient data, a Cochrane review on the role of extended cytoreductive surgery or "ultra-radical surgery" involving complex upper abdominal procedures failed to reveal good quality evidence in favor of these procedures when evaluated against survival as the outcome measure.
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There was also a lack of data on the impact of these procedures on quality of life. This is a reflection of lack of prospective evidence from well-designed randomized trials and a difficulty in standardizing the most important factors impacting on outcome, i.e. disease burden, surgical effort, and surgeon performance.
| Extended cytoreductive procedures for management of advanced stage ovarian cancer
Ovarian cancer is a locoregional disease with locoregional effects leading to symptoms and presentation typical of advanced ovarian cancer. Resection of pelvic disease is often complicated by involvement of the pelvic peritoneum in the pouch of Douglas. Radical excision of pelvic peritoneum requires complete ureterolysis to allow en-bloc resection of the posterior pelvic peritoneum and often a retrograde hysterectomy to facilitate dissection off the rectum (Fig. 7) .
The pelvic disease process may invade into the pelvic colon or its mesentery or present with impending obstruction. Surgery may require primary en-bloc resection of the rectosigmoid colon with low or ultra-low anastomosis to relieve the obstruction or to achieve optimal debulking (Fig. 8) . The technique and results of en-bloc rectosigmoid resection have been well detailed in the literature and the procedure is not without its risks. 51, 52 A gynecologic oncologist should be able to dissect the pararectal and presacral planes to identify the pelvic structures and isolate the disease process.
The ability to perform bowel resection and anastomosis will depend on the training and institutional support. In the event of inability to relieve impending or established bowel obstruction, a gynecologic oncologist should be able to perform a Hartmann procedure and end colostomy, a loop colostomy, and a loop ileostomy.
Diaphragmatic surgery forms part of the extended cytoreductive surgical techniques, which require mobilization of the liver and its attendant risk of injury to the liver, hepatic veins, inferior vena cava and the risks related to the diaphragmatic surgery itself; most Surgical skills for colorectal and urologic procedures are shown in Table 6 .
| FACTORS ASSOCIATED WITH SURGICAL OUTCOMES
It is a well-established fact that surgical, especially oncologic, outcomes vary between surgeons and institutions. 56 This is true for most surgical oncology specialties. Ovarian cancer is one of the conditions for which the impact of surgeon specialty and place of surgery has been addressed extensively in the literature from different parts of the world. In a retrospective review of cases, gynecologic oncologists were more likely to achieve complete or optimal debulking for ovarian cancer and were more likely to adhere to the guidelines for postoperative treatment with platinum-based chemotherapy. The key message from this article is that surgical skill is a continuous spectrum and achieving expertise in complex pelvic surgery is a continuous process that develops over several years. It requires ongoing mentorship, self-reflection, and seeking training opportunities with peers even when the surgical role has transitioned from a trainee to a trainer.
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